Form 4 for MRNA Moderna
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001127602-24-017742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-04 | 2024-05-31 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +232 | 11.0K | +2% | — |
| D | 2024-06-04 | 2024-06-03 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $140.72 | -122 | 10.9K | -1% | -$17.2K |
| D | 2024-06-04 | 2024-05-31 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -232 | 1,629 | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | M | A | 232 | — | 11,000 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 122 | $140.72 | 10,878 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 232 | $0.00 | 1,629 | D | — · — to — | 232 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |